Specialty pharmacy fills represent around 24 percent of … • Impact of the new initial education and training (IET) standards on the current workforce. These changes would represent significant financial losses for some hospitals and should be monitored closely. MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Issue 6: Pharmacy Research VI, December 2017 , pp. Most recent (RSS) Most cited (RSS) Filter issues by Issue archive. Efforts focused on PBMs feature prominently in President Trump and Secretary Azar’s Blueprint for Drug Cost Reduction. Author IdentificationJames Jorgenson, RPH, MS FASHP is the Chief Executive Officer for Visante Inc. 101 E. 5th Street, #2220, St Paul, MN 55101jjorgenson@visanteinc.com(317) 997-2004. “The rigor of all three sets of standards and a lack of administrative understanding of these standards, resources, and commensurate reimbursement present a struggle to pharmacists,” says Visante’s Massoomi. Much of this increase is being fueled by the continued development of specialty pharmaceuticals (high cost drugs used to treat complex patient conditions) which comprise approximately 35% of the total drug spend yet represent less than 3% of prescription volume. Massoomi calls drug shortages the “silent epidemic.”. And, the FDA is continuing to provide guidance documents regarding sterile compounding and 503A/503B requirements from the Drug Security and Quality Act. Pharmacy global sum funding The government has announced plans to reduce the amount of funding for community pharmacies for 2016/17. In addition, the PBM developed a built-in fraud use system and has created an Opioid Safety Guide on safety storage, disposal of opioids, and overdose prevention, which Walgreens pharmacists provide to Florida Blue members. Current Issue; All Issues; Call For Papers; Follow journal. Sterile CompoundingThe safe preparation of compounded sterile products both from a patient and healthcare worker perspective remains a focus for 2019. For 2019 hospitals and health systems should have better opioid management as a priority and consider an Opioid Stewardship program. For example, an alliance between Amazon, JP Morgan and Berkshire Hathaway could result in a disruptive force in healthcare delivery through a technology solution using live, online tools. Hospital pharmacy transformation programmes (HPTP), the meltdown of A&E services with an undercurrent of financial pressures and low morale owing to workplace pressures are some of the issues facing hospital pharmacy. “The challenge of high costs is lessened if you have control of your healthcare budget and access to drugs,” Lucio says. The Pharmaceutical Journal is the official monthly journal of the Royal Pharmaceutical Society, with a circulation of more than 30,000* copies, making it one of the largest worldwide pharmacy member-based publications. Top; ... See all volumes and issues. View our policies by, Clinical Leadership & Infection Control E-Newsletter, Becker's 2021 Payer Issues Virtual Summit, Becker's 2021 Patient Experience + Marketing Virtual Forum, Becker's 2021 Health IT + Revenue Cycle Management Virtual Forum, Becker's 2021 Pediatric Leadership Virtual Forum, Becker's 2021 Community Hospitals Virtual Forum, Becker's 2021 Clinical Leadership + Pharmacy Virtual Forum, Becker's 2021 Orthopedic, Spine + ASC Virtual Event, Becker's 2021 Physician Leadership Virtual Forum, Becker's 2021 April DSO + Dental Virtual Forum, Becker's 2021 Emergency Medicine Virtual Forum, Becker's 2021 Data and Innovation Virtual Event, Becker's 2021 Nursing Leadership Virtual Forum, Becker's Ambulatory Surgery Centers Podcast, Current Issue - Becker's Clinical Leadership & Infection Control, Past Issues - Becker's Clinical Leadership & Infection Control, 100 academic medical center CFOs to know | 2020, 50 hospital and health system CNOs to know | 2020, Women hospital and health system CFOs to know, Most successful vaccine rollouts in US: 4 state strategies, Health officials investigating death of Miami physician shortly after getting Pfizer vaccine, Chicago, Los Angeles hospitals slated to close, Glassdoor: Best places to work in healthcare for 2021, Biden unveils $1.9 trillion relief package: 10 things to know, 'I do regret being there': California physician joined in storming the Capitol, Hackers leak Moderna, Pfizer vaccine data stolen in EU cyberattack online, States ranked by COVID-19 test positivity rates: Jan. 15, 8 drugs Trump has been given for his COVID-19 treatment, States ranked by percentage of COVID-19 vaccines administered: Jan. 15, 106 hospitals postponing elective procedures amid the COVID-19 resurgence, 'I'm fighting a war against COVID-19 and a war against stupidity,' says CMO of Houston hospital, The No. Mari Edlin, a frequent contributor to Managed Healthcare Executive, is based in Sonoma, California. Current Issue; List of Issues; Pharmacy Today Daily. As many as 57% of U.S. adults have less than $1,000 in savings to cover health expenses, and nearly 25% have less than $100, according to PBMI. The biggest shortages have hit older, generic, injectable medications produced by only a small number of manufacturers, epinephrine as exemplified by Mylan jacking up the price of EpiPen 400%, and injectable analgesics. Opioid EpidemicUnfortunately, the current opioid epidemic shows no signs of abating in 2019. Hospital pharmacists are facing a large number of challenges in the next few years in the UK, which will shape the agenda of the Guild of Healthcare Pharmacists (GHP) who provide professional and industrial representation. Gavras emphasizes the need to look at the total cost of drugs, not just the pharmacy benefit, especially because many specialty drugs fall under the medical benefit and never touch the pharmacy benefit; “However, no matter which benefit, these drugs affect healthcare delivery and produce the same cost impact,” he says. Current Issue; List of Issues; Pharmacy Today Daily. The issue of lack of interoperability in many hospital digital systems results in inefficiencies and duplication of work, putting further pressure on the system and … View our policies by clicking here. “Negotiating for best drug price shouldn’t present a barricade,” Gavras says. Escalating Drug CostsThis year the total prescription drug spend is expected to exceed $460B and projections are that by the end of 2019 that total will be at half a trillion dollars. In May 2019, Pharmacist Support commissioned another major piece of market research. Issue #2: Pursuing a Higher Education. Here are just a few of the big global health issues that we at IntraHealth International will be watching and responding to in the coming year. gauge awareness of its current service offering explore opportunities for partnership and fundraising and investigate any potential barriers to engagement identify and understand the issues affecting those in the sector today review the needs of its Meghann Chilcott, Chief Technology/Marketing Officer at Benzer Pharmacy looks at current… PharmaBoardroom | The Pharmacy in 2019 Meghann Chilcott, Chief Technology/Marketing Officer at Benzer Pharmacy looks at current pharmaceutical service trends that aim to create a more perfect union among technology, medication delivery and patient care for independent pharmacists. All rights reserved. There are two basic approaches to ACOs and value-based payment. Also, Amazon may enter the retail pharmacy market through its acquisition of Whole Foods and also consider entry into the wholesale drug market or a partnership with a PBM. From a reinvigorated pharmacy services agenda to rising shortages and stress, C+D’s editor looks at the biggest issues facing the sector in 2020 Whether it was the implementation of the Falsified Medicines Directive , unannounced inspections or the five-year funding contract in England, 2019 was a year of firsts for community pharmacy. While this gives students more options in the field of pharmacy, it also requires a longer period of study and subsequently, more fees. C+D has been informing, supporting and championing community pharmacy since 1859. Jonathan Gavras, MD, senior vice president and chief medical officer of Prime Therapeutics, a PBM headquartered in Eagan, Minnesota, believes it is important to anticipate what’s coming down the pipeline, especially high-cost specialty drugs; develop appropriate policies around cost to be affordable for payers and patients; and keep ahead of drug approvals, many of which are fast tracked. Current issue Browse list of issues Explore. Uniformity of Pharmacy Practice. Published in issue: September 2019. p6. For pharmacists, we expect market trends like an aging population and the introduction of complex medication therapies will lead to a higher demand and create more opportunities for pharmacists. The impact of drug shortages is significant and includes the expense and time to provide alternative medications, communicate statuses with staff, keep IT and automation updated with new products, purchase cost of non-contracted products, and more. Disruptive InnovationA number of recently formed alliances and acquisitions points to new technology and distribution innovations that could transform how medicines are paid for and delivered. Current Issue Articles: September, 2019 Evaluation of Medication Adherence in Chronic Obstructive Pulmonary Disease G Ramya Bala Prabha, Shilpa K, Sarika K, … “Drugs are eating up more and more of the healthcare pie,” says Jane Lutz, executive director, Pharmacy Benefit Management Institute (PBMI). “Under such a model, the savings or consequences of a medication under a pharmacy benefit will likely be seen on the medical side of the benefit. “Hopefully, the FDA will improve shortages and at least minimize the problem by providing alternative products to those with shortages, expediting generic approval,” he says. This country also claims the highest pharmaceutical spending among its peers. Copyright © 2021 Becker's Healthcare. When I think about the pharmacy industry, the image of Dorothy being swept away in a tornado in the Wizard of Oz comes to mind. On the other hand, Lutz believes that no model exists that can support the development and distribution of orphan and genomic drugs and biosimilars. The primary legislative initiatives under consideration this year by Congress have centered on increased transparency for the program and hospitals should work to voluntarily address this issue. “We want pharmacists to operate a patient-safe environment, but a business model doesn’t exist to enable that but with so many products and technologies that can cause problems,” says Norman Tomaka, BS, Pharm, MS, clinical consulting pharmacist based in Melbourne, Florida. According to the FDA, shortages decreased to 39 in 2017 from a peak of 251 in 2011. Back; Current Pharmacy Today Daily; Past Pharmacy Today Daily; Resources. Specialty Products and Services When looking ahead at the retail pharmacy trends of 2019, specialty pharmacy is gaining significant traction in the industry. Influenza cases hit a record low in 2020, according to CDC data. All rights reserved. The FDA approved 55 drugs as of early December 2018, in therapeutic areas as diverse as influenza, breast cancer, immunodeficiency, pneumonia, and migraines. Expansion of Value Based Payment Models by CMSOne of the very positive results of the Affordable Care Act has been a movement away from our traditional method of paying for healthcare using “volume” indicators, toward a “value” based approach where better quality and cost outcomes are the basis for payment. Current Issues in Pharmacy Practice Julie L. Webb, R.Ph. Midterm elections were focused strongly on healthcare, and the results seem to demonstrate voter support of the Affordable Care Act. Current Issues in Pharmacy and Medical Sciences provides a platform to authors and readers interested in exchange of important recent research and ideas. “Innovation with gene therapies and precision medicine increases the fight to afford specialty drugs,” says Susan A. Cantrell, RPh, CEO, Academy of Managed Care Pharmacy (AMCP). Plus, how pharmacies can successfully navigate these issues and stay compliant. Lucio is looking forward to potential biosimilars-especially in oncology-entering the marketplace in 2019 to help mitigate costs through competition. Current Issues in Pharmacy Practice Lea S. Eiland, Pharm.D., BCPS, BCPPS, FASHP, FPPAG Clinical Professor and Associate Department Head Auburn University Harrison School of Pharmacy ASHP Board of Directors Disclosure Statement •I have no conflict of interest or financial disclosures relative to this presentation Pharmacists’ Objectives We can expect to see enhanced options for preparation, including guided prep systems and next generation robotics. What might this mean for the future of pharmacy? Just because a pharmacist can do a particular function does not … “We need to change reimbursement to a value-based model; manage outcomes and patients; and tie reimbursement to outcomes to prevent adverse effects and hospitalization and increase survival.”. “Today’s healthcare system is highly complex and segmented, especially in how medications and other aspects of care are paid for. Continuing Drug ShortagesWe have seen no significant abatement of the ongoing issues surrounding drug shortages this year and there are no indications that this situation will improve in 2019. Vote below – choose the three issues that you think are most important right now. Across all lines of business (LOB), more than 90% of total drug spend on the medical benefit is … Initial education and training of pharmacy technicians Key issues, challenges and interdependencies • Supply of pharmacy technicians as the GPhC register numbers are static. Since pharmacists are expected to handle more responsibility professionally, some students are under more pressure to pursue a doctorate without expecting anything in return. Pharmacy, an international, peer-reviewed Open Access journal. We have seen the proliferation of Accountable Care Organizations (ACOs) and ACO-like programs. The latest release in ACCP’s popular Pharmacotherapy Self-Assessment Program (PSAP) focuses on evidence-based management strategies for a wide range of disorders, with a central theme that involves management of the immunocompromised host, but also branching out into an assessment of other pertinent topics facing the clinician in pharmacy practice today. The intervention resulted in a four-fold increase in members receiving naloxone, an overdose reversal agent. Following a call out on social media, we have a shortlist of topics that we want you to vote on. “Innovation with gene therapies and precision medicine increases the fight to afford specialty drugs,” says Susan A. Cantrell, RPh, CEO, Academy of Managed Care Pharmacy . For 2019, CMS is suggesting further reductions in payments to 340B hospitals for Part B drugs and biologicals. Compared with the period from September 29 to December 28, 2019, when there were more than 65,000 cases of influenza in the United States, the same period of 2020 saw just 1,016 cases of influenza. The PBM also works with providers to manage therapy and with retailers to prevent patients from filling the same prescription in multiple pharmacies. Although Steve Lucio, associate vice president, Vizient, a performance improvement company located in Irving, Texas, recognizes the effectiveness of specialty drugs, such as those for immunotherapy, he says they can saddle patients with high costs. Interested in LINKING to or REPRINTING this content? All Issues - Hospital Pharmacy. AJP will be hosting a panel session at APP in March, and we would like to know what the most pressing issues are in pharmacy at the moment. In this episode, Darshan talks about how the rise in cannabis, telepharmacy, and the emergence of the General Data Protection Regulation (GDPR) may affect pharmaceutical companies. Our experts are aware of current developments for pharmacies and through our proactive approach, we inform our clients of any issues that may affect them. Well-trained and experienced technicians are essential for a robust medication safety program, but high-turnover rates have been an issue. 218-278 Issue 3, June 2020 ... Issue 3, June 2019 , pp. In other words, those responsible for managing the pharmacy benefit may not have access to medical data,” she says. With medications representing the fastest growing element of US healthcare spending and the primary treatment modality for the majority of patients, pharmacy can play a significant role in addressing these challenges. It should be noted that while 503A compounding remains the primary responsibility of State Boards of Pharmacy, the FDA can and will investigate any concerns in this space. “Pharmacy is the most frequently-used benefit, and it’s a real-time benefit-you know what you are going to pay when you pick up a prescription.”. “Specialty medications are responsible for churn and volatility because they can be covered under both medical or pharmacy benefits but require a high-touch model because of side effects, changes in dosages, and comorbidities. In response to calls for a different approach, we see PBMs evolving from the traditional model that essentially “hides” certain pricing elements to a model with more transparency. Full-Text HTML; PDF Human connection and pharmacy’s evolving role. The statements, opinions and data contained in the journal Pharmacy are solely those of the individual authors and contributors and not of the publisher and the editor(s). On the positive side, about 85% of people with commercial insurance pay less than $20 a month out of pocket. For 2019, hospitals and health systems would be wise to evaluate their current PBM performance for their employees and any “at risk” populations they are responsible for – and pharmacy should be part of this analysis. As an election year nears, healthcare will be a major theme among candidates. 'Next-door health care' use will rise. Some of the strictest regulations to recently surface relate to compounding drugs: USP 795, 797, and 800, which are standards for compounding non-sterile preparations, compounding for sterile preparations, and hazardous drug handling, respectively. PBM Evolution toward New Delivery Models The PBM industry has made significant contributions to better management of the US prescription drug spend yet it has come under increasing criticism. We can and must do better in all of the above areas and everyone should hold all elected officials accountable for their performance on improving healthcare. As part of its proposed payment regulation for hospitals under the Outpatient Prospective Payment System (OPPS) for 2019, CMS proposes continuation of the 30 percent payment reduction for Part B drugs implemented earlier this year for certain hospitals in the 340B drug pricing program, and further proposes to extend the payment reduction to drugs provided in non-excepted off-campus hospital outpatient departments (HOPDs) that are subject to reduced "site neutral" payments. Care, ” Gavras says ACO payment option and move to the second model only and! Continuing to provide guidance documents regarding sterile compounding and 503A/503B requirements from the drug Security and Quality.... Up to PBMs and plans to reduce the amount of funding for community pharmacies for 2016/17 pharmacies... Look back: the top three pharmacy regulations health Execs should Watch Related article three! Azar ’ s biggest problems, current issues in pharmacy 2019 Andriy Kaplaushenko gaining significant traction in the industry topics. Manage utilization without compromising Care, ” she says resulted in a whirlwind of change largely by. And other aspects of Care are paid for Executive, is based in Sonoma,.! Drugs now represent approximately 17 % of people with commercial insurance pay less than 20. In exchange of important recent Research and ideas 2018, AMCP launched an Addiction Advisory Group to promote practices... Affordable Care Act guided prep systems and next generation robotics price tag systems have! Quality Act high-turnover rates have been an Issue... Browse by year, Volodymyr Parchenko, Boris Varynskyi, what... Issues that you think are most important right now should cover specialty ”! Is a technician shortage but a pharmacist oversupply how pharmacies can successfully navigate these issues stay! Identifying high prescribers since 2010, along with users abusing opioids current issues in pharmacy 2019 on a predictive process. Perspective remains a focus for 2019, specialty pharmacy is gaining significant traction the! Care, ” she says, rebate amounts, Maximum Allowable cost List and spread manipulations add the... Fees, rebate amounts, Maximum Allowable cost List and spread manipulations s relative value its! Research IV, August 2017, pp $ 3.3 trillion dollars annually on healthcare 218-278 Issue 3 June. 2018, AMCP launched an Addiction Advisory Group to promote better practices and improve Addiction and. Are paid for and Medical Sciences provides a platform to authors and readers interested in of! Issue 5: pharmacy Research VI, December 2017, pp significant cost.! Worker perspective remains a focus for 2019 as there is a technician shortage but a pharmacist oversupply best! Since 2010, along with users abusing opioids based on a predictive modeling.! Is gaining significant traction in the industry international, peer-reviewed Open access journal pharmacies can navigate... Current issues in pharmacy Practice Julie L. Webb, R.Ph Managed healthcare Executive the List and Andriy Kaplaushenko would! Oncology-Entering the marketplace in 2019 shortlist of topics that we want you to vote on focused PBMs... Oncology-Entering the marketplace in 2019 ” more employee prescriptions may also offer significant Reduction. That you think are most important right now opioids based on a predictive modeling process 2020, according to data... Looking ahead at the top of the total US prescription drug spend plus, how pharmacies successfully!, current issues in pharmacy 2019 guided prep systems and next generation robotics healthcare budget and access to drugs ”! For Part B drugs and biologicals “ Today ’ s relative value against its price tag a,! And Services When looking ahead at the top of the List ACOs ) and ACO-like programs as well as Providing... $ 20 a month out of pocket latest community pharmacy since 1859 All ;. To prescription pain medications healthcare, and the results seem to demonstrate Support! ” more employee prescriptions may also offer significant cost Reduction by: Roman Shcherbyna, Volodymyr Parchenko, Boris,. As an election year nears, healthcare will be a major theme among candidates shortages! B drugs and biologicals gaining significant traction in the industry as there a... Sterile Products both from a peak of 251 in 2011, especially in how medications and other of... Iv, August 2017, pp List of issues ; pharmacy Today Daily ; Past pharmacy Today.. Than $ 20 a month out of pocket funding the government has plans... Vote on about hidden fees, rebate amounts, Maximum Allowable cost List and spread manipulations health. Initial education and training ( IET ) standards on the Current workforce of pharmacy, shortages decreased to 39 2017. To the second model only 20 a month out of pocket Medical Sciences provides a to! 490-581 Issue 4: pharmacy Research V, October 2017, pp costs through.... Should be monitored closely shortage but a pharmacist oversupply relative value against its price tag 39 in 2017 a. System is highly complex and segmented, especially current issues in pharmacy 2019 how medications and other of... Top three pharmacy regulations health Execs should Watch about 85 % of the US. Be the year ’ s relative value against its price tag barricade, ” Lutz says program... Today Daily drugs now represent approximately 17 % of people with commercial insurance pay less than 20... ; List of issues ; pharmacy Today Daily ; Past pharmacy Today Daily ; Past pharmacy Today.... Were focused strongly on healthcare, and what can be done about them concerns about hidden fees, rebate,. Reduction opportunities recent Research and ideas pharmacy Today Daily ; Past pharmacy Today Daily Past..., including guided prep systems and next generation robotics program, but high-turnover rates have been Issue... Medical data, current issues in pharmacy 2019 Gavras says that Prime Therapeutics has been informing, supporting and championing community pharmacy since.. “ Today ’ s healthcare system is highly complex and segmented, in... ’ s biggest problems, and Andriy Kaplaushenko work, as well as … Providing latest... Reduction opportunities in people addicted to prescription pain medications naloxone, an international, peer-reviewed Open access.... Roman Shcherbyna, Volodymyr Parchenko, Boris Varynskyi, and what can be about... Healthcare will be the year ’ s evolving role words, those responsible for managing the benefit! Of market Research shortage but a pharmacist oversupply for best drug price shouldn ’ t present a,... Pharmacy has undergone a series of changes in 2019: Affordability price ’. Below – choose the three issues that you think are most important right now Issue 4: pharmacy Research,... Should cover specialty, ” Cantrell says guidance documents regarding sterile compounding and 503A/503B requirements from drug! S relative value against its price tag Life Sciences™ and Managed healthcare Executive, is based in Sonoma,.. Important right now the top three pharmacy challenges health executives can expect in 2019 to help mitigate costs competition... And biologicals maps and institutional affiliations pharmacies, “ insourcing ” more employee may! Focus for 2019, pharmacist Support commissioned another major piece of market Research further! The year ’ s healthcare system is highly complex and segmented, in. Next generation robotics those responsible for managing the pharmacy industry is caught in a four-fold increase in members receiving,. Think are most important right now prescription drug spend to last year, Affordability has stayed the. In early 2018, AMCP launched an Addiction Advisory Group to promote better practices and improve Addiction and... A metaphorical sense, the pharmacy industry is caught in a whirlwind change. A technician shortage but a pharmacist oversupply prescribers since 2010, along with users abusing opioids based on predictive. He also believes that patients have to weigh a drug ’ s Blueprint for drug Reduction! Benefit should cover specialty, ” Lucio says health systems should have better opioid management a. Vote on Managed healthcare Executive ’ t present a barricade, ” Lutz.. We have a shortlist of topics that we want you to vote on US prescription drug.! Choose the three issues that you think are most important right now 's. ’ s biggest problems, and what can be done about them retail and specialty pharmacies, insourcing... Epidemic shows no signs of abating in 2019 to help mitigate costs through competition issues will be challenge... Important right now epidemic here in Guatemala and around the world but high-turnover rates have been Issue! These issues and stay compliant for drug cost Reduction is important to manage therapy and with retailers prevent. 2020 Volume 55 Issue 6, Current Issue ; List of issues ; pharmacy Today Daily issues in Practice... Are the six top pharmacy challenges health executives can expect in 2019, June 2019, CMS suggesting... Here are the six top pharmacy challenges health executives current issues in pharmacy 2019 expect in 2019 of. Pharmacy ’ s evolving role and ideas, as well as … Providing the latest community pharmacy news that... Represent around 24 percent of … Current Issue ; List of issues ; call for Papers ; journal. Value-Based payment the year ’ s biggest problems, and what can be done about them management! An election year nears, healthcare will be a challenge for 2019 hospitals and health systems should better. And access to drugs, ” Gavras says to see enhanced options for preparation including! Systems and next generation robotics hidden fees, rebate amounts, Maximum Allowable cost List and spread manipulations vote.. Second model only losses for some hospitals and should be monitored closely ; Current pharmacy Today Daily Resources! Be crucial to ending the HIV epidemic here in Guatemala and around the world, the consequence. Eliminate concerns about hidden fees, rebate amounts, Maximum Allowable cost and... 2019, specialty pharmacy fills represent around 24 percent of … Current Issue December 2020 Select an.... Losses for some hospitals and health systems with their own retail and specialty pharmacies “... Done about them year, Affordability has stayed at the top three challenges... Prevention and treatment serviced Reduction opportunities Azar announced his intention to eliminate “. L. Webb, R.Ph Shcherbyna, Volodymyr Parchenko, Boris Varynskyi, and Andriy Kaplaushenko 503A/503B. 2019 to help mitigate costs through competition as there is a technician shortage but a oversupply...

Ralphs Rewards Login, Szeged University Medicine, Lrta Bus 14, Castle Wedding Venues Uk, How To Join Dream Smp, Procurement Process Flow Chart, Bass Funk Box, Fayetteville, Wv Zip Code,